ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
10.96
-0.01 (-0.09%)
Nov 20, 2024, 4:00 PM EST - Market closed
ClearPoint Neuro Employees
ClearPoint Neuro had 107 employees as of December 31, 2023. The number of employees decreased by 1 or -0.93% compared to the previous year.
Employees
107
Change (1Y)
-1
Growth (1Y)
-0.93%
Revenue / Employee
$284,383
Profits / Employee
-$169,598
Market Cap
302.33M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sage Therapeutics | 487 |
Lyell Immunopharma | 224 |
Nyxoah | 147 |
C4 Therapeutics | 145 |
Kodiak Sciences | 111 |
Atai Life Sciences | 83 |
Design Therapeutics | 58 |
Jasper Therapeutics | 45 |
CLPT News
- 7 days ago - ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain - Accesswire
- 10 days ago - ClearPoint Neuro: Near-Term Volatility Is No Concern - Seeking Alpha
- 13 days ago - ClearPoint Neuro, Inc. (CLPT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 13 days ago - ClearPoint Neuro Reports Third Quarter 2024 Results - Accesswire
- 20 days ago - ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024 - Accesswire
- 4 weeks ago - ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024 - GlobeNewsWire
- 3 months ago - ClearPoint Neuro Announces Early Repayment of $10 Million Note - GlobeNewsWire
- 3 months ago - ClearPoint: Growth Tailwinds Are Only Just Beginning To Emerge (Rating Downgrade) - Seeking Alpha